Le Lézard
Classified in: Health, Science and technology
Subject: VET

RPP Announces 4 Breakthrough Products Now Available to Veterans and Active Military


PALM HARBOR, Fla., Dec. 6, 2017 /PRNewswire/ -- Dr. C. Randall Harrell, the Chief Medical Officer (CMO) of Regenerative Processing Plant (RPP), was recently the keynote speaker at the Veteran's Support Services Awards Gala on Veterans Day.

Dr. Harrell discussed burn pit inhalation injuries in active military and veterans, as well as his discovery of the First-in-Class next generation treatment: The PurAcel® Inhalation Solution, now available on DAPA.

PurAcel® Inhalation Solution is an option for active military and veterans who are suffering with lung damage due to various causes. A clinical trial, in conjunction with the Atlanta VA, is in early stages.

RPP's other innovative regenerative products are now available and listed on DAPA (therefore accessible to all active military and veterans) and include iRegen® and RegenaMax® Liquid and Tissue Allografts.

iRegen® is a self-administered eye treatment that may help with mild to severe dry eyes and may help some ocular injuries. It may be a superior substitute for the older technology of autologous tears as well as an advanced healing alternative to amniotic membrane. Patients no longer have to put up with time-consuming, painful procedures to solve their eye problems.

RegenaMax® Liquid Allograft can be administered through a 30-gauge needle. Other soft tissue and joint injuries can take a minimum of 3-12 months to see relief, RegenaMax's 3-phase treatment approach can have immediate relief potential and ongoing possible regenerative effects.

RegenaMax® Tissue Allograft is a wound management product that fosters healing of various injuries.

OF SIGNIFICANCE: All 4 products are acellular stem cell stimulators derived from RPP's patented technology. People who suffer from debilitating injuries or illness may be able to return to their regular lives and activities without surgical procedures. All four products have been shown to help with injuries that have been slow to heal or are unresponsive to other treatments.

About Dr. Harrell: Dr. Harrell is considered the Father of Regenerative Medicine. His patented, novel platform technologies such as Sterile D-MAPPS and other innovative products allow for a new standard of care for our active military and veterans, and others who suffer from chronic injuries and illnesses.

About Regenerative Processing Plant, LLC: RPP is a BioPharma company that is a pioneer in the rapidly growing field of Regenerative Medicine. Its visionary CMO is Dr. C. Randall Harrell, who invented and developed patent-protected and proprietary next generation platform technologies and a series of novel biologics for both the commercial market as well as the VA and DoD. These innovative products were designed to meet urgent needs in the fields of pulmonary, burns, wound care, pain, orthopedics, and ophthalmology.

If you would like more information about this topic, please contact our COO, Crissy Fellabaum, PhD, at (800) 781-0818 or email at [email protected].

SOURCE Regenerative Processing Plant, LLC


These press releases may also interest you

at 11:32
Demandbase, the leader in AI-driven account-based go-to-market (GTM), today announced that it has not only been recognized as a leader in numerous G2 Spring Reports, it has also achieved a highly coveted placement on G2's Best Marketing & Digital...

at 11:25
The "Consumer Brain-Computer Interface: Market and Product Development Trends" report has been added to ResearchAndMarkets.com's offering. Over the past decade, brain-computer interface (BCI) technology has expanded beyond the confines of the...

at 11:25
Caravelle International Group , a global ocean technology company, today announced that it received a notice from The Nasdaq Stock Market LLC indicating that, as a result of not having timely filed its Annual Report on Form 20-F for the fiscal year...

at 11:19
On 29 March 2024, BTR New Material Group Co., Ltd. ("BTR")(835185.BJ), a global leader in battery materials, inked an investment agreement with the Moroccan government to erect a lithium battery ternary cathode material facility in the country. The...

at 11:13
Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. (Laborie)?announced its investment in iO Urology, a venture-backed medical technology company that developed CarePath® an at-home, handheld uroflow...

at 11:08
AERKOMM Inc. (Euronext: AKOM, OTCQX: AKOM, "AERKOMM"), an innovative satellite technology company providing multi-orbit broadband connectivity solutions, and IX Acquisition Corp , a SPAC focused on the technology, media and telecommunications...



News published on and distributed by: